Oppenheimer Asset Management Inc. grew its holdings in shares of Omega Healthcare Investors, Inc. (NYSE:OHI – Free Report) by 229.8% during the third quarter, HoldingsChannel reports. The institutional investor owned 22,901 shares of the real estate investment trust’s stock after buying an additional 15,958 shares during the period. Oppenheimer Asset Management Inc.’s holdings in Omega Healthcare Investors were worth $932,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors have also recently modified their holdings of the business. Allworth Financial LP grew its position in Omega Healthcare Investors by 12.0% in the 3rd quarter. Allworth Financial LP now owns 2,276 shares of the real estate investment trust’s stock valued at $93,000 after acquiring an additional 244 shares during the last quarter. Venturi Wealth Management LLC grew its holdings in shares of Omega Healthcare Investors by 29.4% in the third quarter. Venturi Wealth Management LLC now owns 1,259 shares of the real estate investment trust’s stock worth $51,000 after purchasing an additional 286 shares during the last quarter. Cutter & CO Brokerage Inc. increased its stake in Omega Healthcare Investors by 3.7% in the 2nd quarter. Cutter & CO Brokerage Inc. now owns 8,206 shares of the real estate investment trust’s stock worth $281,000 after buying an additional 290 shares during the period. NCP Inc. lifted its holdings in Omega Healthcare Investors by 10.3% during the 2nd quarter. NCP Inc. now owns 3,310 shares of the real estate investment trust’s stock valued at $113,000 after buying an additional 310 shares in the last quarter. Finally, V Square Quantitative Management LLC boosted its position in Omega Healthcare Investors by 49.5% in the 3rd quarter. V Square Quantitative Management LLC now owns 976 shares of the real estate investment trust’s stock valued at $40,000 after buying an additional 323 shares during the period. 65.25% of the stock is currently owned by hedge funds and other institutional investors.
Insider Buying and Selling at Omega Healthcare Investors
In other Omega Healthcare Investors news, CFO Robert O. Stephenson sold 22,542 shares of the firm’s stock in a transaction that occurred on Friday, September 27th. The shares were sold at an average price of $40.19, for a total value of $905,962.98. Following the completion of the sale, the chief financial officer now directly owns 183,076 shares in the company, valued at $7,357,824.44. This trade represents a 10.96 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, COO Daniel J. Booth sold 56,725 shares of the firm’s stock in a transaction that occurred on Friday, September 27th. The shares were sold at an average price of $40.25, for a total transaction of $2,283,181.25. Following the completion of the sale, the chief operating officer now owns 100,000 shares of the company’s stock, valued at approximately $4,025,000. This trade represents a 36.19 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.37% of the stock is owned by insiders.
Omega Healthcare Investors Stock Performance
Omega Healthcare Investors Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Friday, November 15th. Shareholders of record on Monday, November 4th were paid a $0.67 dividend. The ex-dividend date of this dividend was Monday, November 4th. This represents a $2.68 annualized dividend and a yield of 6.78%. Omega Healthcare Investors’s dividend payout ratio (DPR) is 197.06%.
Analyst Upgrades and Downgrades
A number of equities analysts have recently commented on OHI shares. BNP Paribas raised shares of Omega Healthcare Investors from a “neutral” rating to an “outperform” rating and set a $49.00 target price on the stock in a research report on Thursday, October 31st. Mizuho lowered shares of Omega Healthcare Investors from an “outperform” rating to a “neutral” rating and raised their target price for the stock from $34.00 to $35.00 in a research report on Thursday, July 25th. Scotiabank raised their target price on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the stock a “sector perform” rating in a research report on Monday, August 26th. Royal Bank of Canada raised their target price on shares of Omega Healthcare Investors from $39.00 to $43.00 and gave the stock a “sector perform” rating in a research report on Monday, November 11th. Finally, Wells Fargo & Company reaffirmed an “overweight” rating and set a $43.00 target price (up from $40.00) on shares of Omega Healthcare Investors in a research report on Tuesday, October 1st. Seven equities research analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $40.00.
Check Out Our Latest Stock Report on Omega Healthcare Investors
Omega Healthcare Investors Profile
Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.
Featured Articles
- Five stocks we like better than Omega Healthcare Investors
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- Is Monolithic Power Systems a Screaming Buy After Near 40% Drop?
- About the Markup Calculator
- Applied Materials Market Capitulates: Now is the Time to Buy
- What is a Low P/E Ratio and What Does it Tell Investors?
- 3 Ultra-High Dividend Yield Stocks for the New Year
Want to see what other hedge funds are holding OHI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Omega Healthcare Investors, Inc. (NYSE:OHI – Free Report).
Receive News & Ratings for Omega Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.